Use of compound 1 in treatment or prevention of atopic dermatitis
AssigneeShenzhen Newdel Biotech Co., Ltd.
InventorsXun HE, Feng JIN, Yuhan GUO, Tianyuan ZHANG, Zhenwei LI, Ying ZHANG, Wei HU
Life of this patent
Estimating the term…
Abstract
The present invention relates to use of N-(3-chloro-5-(trifluoromethyl)phenyl)-3-((6-(4-hydroxypiperidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)ethynyl)-2-methylbenzamide (also referred to herein as compound 1) or a pharmaceutically acceptable salt thereof in the treatment or prevention of atopic dermatitis.
Claims10
(canceled)
A method for treating or preventing atopic dermatitis, comprising administering to a subject a therapeutically effective amount of compound 1 or a pharmaceutically acceptable salt of the compound 1, wherein the compound 1 has following structure:
A pharmaceutical composition for treating or preventing atopic dermatitis, comprising compound 1 or a pharmaceutically acceptable salt of the compound 1, and a pharmaceutically acceptable excipient, wherein the compound 1 has following structure:
Compound 1 or a pharmaceutically acceptable salt of the compound 1 for use in treatment or prevention of atopic dermatitis, wherein the compound 1 has following structure:
Dependencies are inferred from the claim text.